Modular in vivo antibody–ADC click to reverse drug resistance in tumours
New cancer treatment approach uses click chemistry to assemble antibodies and reverse drug resistance
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A novel approach to cancer treatment is gaining attention, involving the use of click chemistry to assemble antibodies and create a drug that can target cancer cells.
Coverage from various outlets, including EurekAlert!, WashU Medicine, and Nature, emphasizes the potential of this new method to supercharge cancer medication and reverse drug resistance in tumors.
The development of this approach and its applications are being closely watched, with key questions surrounding its effectiveness and potential uses.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. Updated just now.
Quick answers
What is the new approach to cancer treatment?
The new approach involves using click chemistry to assemble antibodies and create a drug that can target cancer cells.
Which outlets are covering this story?
EurekAlert!, WashU Medicine, Nature, Lebanon Democrat, and Oncodaily are covering this story.
What is the goal of this new approach?
The goal is to reverse drug resistance in tumors and supercharge cancer medication.
Coverage (5)
- ‘Game changer’ drug turns cancer’s defenses against itself Lebanon Democrat · 1d ago
- Click chemistry antibodies bind to pancreatic cancer cells (IMAGE) EurekAlert! · 1d ago
- New approach to designing drugs supercharges cancer medication WashU Medicine · 1d ago
- George L․ Kumar: What If Two Antibodies Could Find Each Other and Assemble a Cancer Drug? Oncodaily · 1d ago
- Modular in vivo antibody–ADC click to reverse drug resistance in tumours Nature · 1d ago broke it first
People, places & organizations
Topics
Related trends
Rare transplant gives Stage 4 lung cancer patients a second chance at life
7 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
Deadly drug-resistant fungal infections rising in the U.S.
Drug-resistant Candida auris infections are rising across U.S. hospitals, posing a severe threat to patient safety.